RxDoctor Payments Data

Alexa de la Torre

Physician Assistant · Massapequa, NYNPI 1083269450

Payments from drug & device makers

$5,267in general payments, 2019–2025

Across 260 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$813
  • AbbVie$783
  • Teva Pharmaceuticals USA, Inc.$612
  • Lundbeck LLC$442
  • Otsuka America Pharmaceutical, Inc.$437
  • Corium, LLC$352
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,267100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,267 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$18,254
TrintellixVortioxetine Hydrobromide12$7,324
VyvanseLisdexamfetamine Dimesylate19$6,992
QuviviqDaridorexant Hcl11$5,560
Asenapine Maleate11$5,182
Lamotrigine ErLamotrigine14$2,470
Duloxetine Hcl60$1,987
Aripiprazole63$1,709
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$907
Quetiapine Fumarate65$702
Clonazepam68$598
Alprazolam102$532
Trazodone Hcl44$363
Lamotrigine69$337
Sertraline Hcl49$305

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$437$18,25412 claims
Idorsia Pharmaceuticals US IncQuviviq$162$5,56011 claims
Almatica Pharma LLCSertraline Hcl$92$30549 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Massapequa

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →